Name: LYEL Balance Sheet - Lyell Immunopharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

LYEL - Lyell Immunopharma, Inc.

USD | NASDAQ | Healthcare

LYEL Balance Sheet - Lyell Immunopharma Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Cash And Short Term Investments
Cash And Equivalents	60.2	105.6	145.6	123.6	293.8	140.4	96.7	-
Restricted Cash	-	-	-	-	-	-	-	-
Short Term Investments	187.0	264.9	400.6	516.6	321.0	472.2	-	-
Cash And Short Term Investments	247.2	370.5	546.2	640.2	614.8	612.6	96.7	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-
Prepaid Expenses	13.7	9.1	8.5	11.1	11.5	4.9
Non-Current Assets
Property, Plant & Equipment Gross	109.0	118.9	154.3	155.4	134.6	82.1	-	-
Accumulated Depreciation	74.3	70.7	51.6	32.4
Current Liabilities
Accounts Payable	2.9	5.4	4.8	3.9	3.2	9.4	-	-
Short Term Debt	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	41.9	51.0	56.9	63.2	66.7
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	1,867.5	1,727.6	1,657.1	1,608.3	1,515.7
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q4 FY 18
Cash And Short Term Investments
Cash And Equivalents	90.8	60.2	123.6	98.8	120.3	105.6	100.3	133.4	125.7	145.6	286.2	224.4	109.4	123.6	116.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	13.3	13.7	8.6	5.4	8.0	9.1	9.5	8.7	7.9	8.5	11.4	10.7	11.6	11.1	11.6	11.2	11.8	11.5
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	267.3	260.9	328.2	282.2	309.2	379.6	450.0	499.8	534.2	554.7	586.9	606.4	624.4	651.3	659.7	666.8

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	32.7	34.8	36.7	39.1	44.2	48.2	88.0	93.1	97.8	102.7	108.1	113.7	118.6	123.0	125.7	127.6
Long Term Investments	7.0	0.0	0.0	20.1	28.9	13.0	20.1	0.0	0.0	16.5	22.7	37.0	55.3	70.1	102.5	131.4	224.1
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	17.8	18.9	19.9	21.0	23.6	24.7	36.7	37.7	38.7	39.7	40.6	41.5	42.4	43.2	44.1	44.9
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	5.2	4.9	2.5	2.5	3.2	4.6	5.1	4.2	4.2	4.2	4.4	4.5	4.6	4.7	2.9	3.7	3.6
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	350.6	340.1	408.0	385.5	429.8	490.9	619.2	654.1	694.2	750.0	795.0	835.4	880.5	937.6	977.3	1,021.7	1,072.1

Current Liabilities
Accounts Payable	5.5	2.9	2.6	3.4	3.7	5.4	3.6	4.2	4.9	4.8	4.4	5.8	5.7	3.9	4.8	4.2	6.5	3.2	3.5	4.9	-	9.4	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11.2	15.4	6.2
Operating Lease Liabilities Current	9.4	-	8.8	8.5	8.2	-	7.1	6.9	6.7	-	6.1	5.9	4.8	-	2.8	1.5
Accrued Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	36.9	49.4	31.9	36.9	41.3	53.8	33.5	30.9	32.4	34.5	35.1	34.4	30.8	37.0	51.2

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	39.5	41.9	44.3	46.6	48.9	51.0	51.4	53.3	55.2	56.9	58.6	60.2	61.8	63.2	64.6	66.1
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37.2	32.9	77.9
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	0.5	0.5	2.7	3.0	3.1	3.3	3.6	3.4	3.6	3.7	3.8	3.9	4.0	4.1	4.2	4.3
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	77.0	91.9	78.8	86.5	93.3	108.0	88.5	87.6	91.1	95.1	97.4	98.5	96.6	104.3	157.2	153.6

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	0.0	-	-	-	-	-
Additional Paid In Capital	1,917.4	1,867.5	1,807.7	1,738.9	1,733.6	1,727.6	1,683.1	1,675.5	1,666.3	1,657.1	1,647.9	1,637.5	1,622.1	1,608.3	1,589.1	1,565.2
Retained Earnings	(1,643.7)	(1,619.6)	(1,478.8)	(1,440.0)	(1,397.3)	(1,345.1)	(1,153.2)	(1,108.6)	(1,062.8)	(1,002.1)	(949.2)	(898.3)	(834.4)	(767.5)	(759.1)	(688.8)	(652.5)
Accumulated Other Comprehensive Income	(0.0)	0.2	0.2	0.1	0.2	0.3	0.8	(0.4)	(0.4)	(0.1)	(1.2)	(2.4)	(3.9)	(7.6)	(10.0)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	273.7	248.2	329.1	298.9	336.5	382.8	530.7	566.5	603.2	655.0	697.6	736.9	783.8	833.3	820.0	868.0	881.2
Total Equity	273.7	248.2	329.1	298.9	336.5	382.8	530.7	566.5	603.2	655.0	697.6	736.9	783.8	833.3	820.0	868.0	881.2	929.8